Abstract
Acanthamoebae are free-living amoebae distributed worldwide. They are among the most prevalent protozoa found in the environment, and have been isolated from a wide variety of public water supplies, swimming pools, bottled water, ventilation ducts, soil, air, surgical instruments, contact lenses, dental treatment units and hospitals. Acanthamoebae feed on bacteria by phagocytosis, but some bacteria are able to survive and sometimes multiply in the host, resulting in new properties of the bacteria. The intracellular growth of bacteria has been associated with enhanced environmental survival of the bacteria, increased virulence and increased resistance against antibiotic substances. The advantage of utilising free-living amoebae is that research can be carried out on non-mammalian cells as a model based on natural reality to study bacterial virulence and pathogenicity. Amoebae are easy to handle experimentally compared with mammalian cells and allow studies on host factors for host-parasite interactions. Bacteria are easily manipulated genetically, which creates the possibility of research on mutants to study bacteria-host interactions. Thus utilising this non-mammalian model can result in better understanding of interactions between prokaryotic and eukaryotic cells and assist in the development of new therapeutic agents to recognise and treat infections.
Keywords: Amoeba, antibiotic, bacteria, interaction, symbionts, symbiosis, Acanthamoeba-Bacteria, pathogens, protozoa, Mycobacterium, Legionella
Current Drug Targets
Title: Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens
Volume: 12 Issue: 7
Author(s): Gunnar Sandstrom, Amir Saeed and Hadi Abd
Affiliation:
Keywords: Amoeba, antibiotic, bacteria, interaction, symbionts, symbiosis, Acanthamoeba-Bacteria, pathogens, protozoa, Mycobacterium, Legionella
Abstract: Acanthamoebae are free-living amoebae distributed worldwide. They are among the most prevalent protozoa found in the environment, and have been isolated from a wide variety of public water supplies, swimming pools, bottled water, ventilation ducts, soil, air, surgical instruments, contact lenses, dental treatment units and hospitals. Acanthamoebae feed on bacteria by phagocytosis, but some bacteria are able to survive and sometimes multiply in the host, resulting in new properties of the bacteria. The intracellular growth of bacteria has been associated with enhanced environmental survival of the bacteria, increased virulence and increased resistance against antibiotic substances. The advantage of utilising free-living amoebae is that research can be carried out on non-mammalian cells as a model based on natural reality to study bacterial virulence and pathogenicity. Amoebae are easy to handle experimentally compared with mammalian cells and allow studies on host factors for host-parasite interactions. Bacteria are easily manipulated genetically, which creates the possibility of research on mutants to study bacteria-host interactions. Thus utilising this non-mammalian model can result in better understanding of interactions between prokaryotic and eukaryotic cells and assist in the development of new therapeutic agents to recognise and treat infections.
Export Options
About this article
Cite this article as:
Sandstrom Gunnar, Saeed Amir and Abd Hadi, Acanthamoeba-Bacteria: A Model to Study Host Interaction with Human Pathogens, Current Drug Targets 2011; 12 (7) . https://dx.doi.org/10.2174/138945011795677845
DOI https://dx.doi.org/10.2174/138945011795677845 |
Print ISSN 1389-4501 |
Publisher Name Bentham Science Publisher |
Online ISSN 1873-5592 |
Call for Papers in Thematic Issues
Drug-Targeted Approach with Polymer Nanocomposites for Improved Therapeutics
Polymer nanocomposites have been recognized as an advanced and cutting-edge technique in drug targeting administration. These materials combine the unique features of nanoparticles with the adaptability of polymers to produce highly personalized drug administration devices. Integrating nanoparticles containing pharmaceuticals into a polymer matrix enables researchers to regulate the rates at ...read more
RNA Molecules in the Treatment of Human Diseases
Messenger and non-coding RNAs, including long and small transcripts, are mediators of gene expression. Gene expression at the RNA level shows significant aberrations in human diseases, including cancer, leukemia, lymphoma, cardiovascular diseases, and neurological disorders. Human transcripts serve either as biomarkers of diagnosis, prognosis, prediction of treatment response, and/or therapy ...read more
Therapeutic Chemical and RNA Design with Artificial Intelligence
Computer-Aided Drug Design (CADD) has emerged as a fundamental component of modern drug discovery. Molecular docking facilitates virtual screening on a large scale through structural simulations. However, traditional CADD approaches face significant limitations, as they can only screen known compounds from existing libraries. PubChem, as the most widely used chemical ...read more
- Author Guidelines
- Graphical Abstracts
- Fabricating and Stating False Information
- Research Misconduct
- Post Publication Discussions and Corrections
- Publishing Ethics and Rectitude
- Increase Visibility of Your Article
- Archiving Policies
- Peer Review Workflow
- Order Your Article Before Print
- Promote Your Article
- Manuscript Transfer Facility
- Editorial Policies
- Allegations from Whistleblowers
Related Articles
-
Efficacy and Toxicity of Clioquinol Treatment and A-beta42 Inoculation in the APP/PSI Mouse Model of Alzheimer's Disease
Current Alzheimer Research SARS-CoV-2 Proteins: Are They Useful as Targets for COVID-19 Drugs and Vaccines?
Current Molecular Medicine Systems Biology of Apoptosis and Survival: Implications for Drug Development
Current Pharmaceutical Design The Beneficial Role of Vitamin D in Human Immunodeficiency Virus Infection
Current HIV Research Optic Neuritis: A Model for the Immuno-pathogenesis of Central Nervous System Inflammatory Demyelinating Diseases
Current Immunology Reviews (Discontinued) Heparanase Patents: Dim Past and Bright Future
Recent Patents on Inflammation & Allergy Drug Discovery Mechanism(s) Involved in Opioid Drug Abuse Modulation of HAND
Current HIV Research Clinical Significance of Cytokines and Chemokines in Neuropsychiatric Systemic Lupus Erythematosus
Current Rheumatology Reviews COVID-19 and Alzheimer's Disease: Neuroinflammation, Oxidative Stress, Ferroptosis, and Mechanisms Involved
Current Medicinal Chemistry A DNA Barcoding Based Study to Identify Main Mosquito Species in Taiwan and its Difference from Those in Mainland China
Combinatorial Chemistry & High Throughput Screening Peptides as Signaling Inhibitors for Mammalian MAP Kinase Cascades
Current Pharmaceutical Design New Neuroimaging Findings in Patients with Molybdenum Cofactor Deficiency Type A: A Case Report and Literature Review
Current Medical Imaging A Review of miRNA Regulation in Japanese Encephalitis (JEV) Virus Infection
Current Pharmaceutical Biotechnology Radiolabeled Nucleoside Analogues for PET Imaging of HSV1-tk Gene Expression
Current Topics in Medicinal Chemistry Experimental and Clinical Application of Plasmid DNA in the Field of Central Nervous Diseases
Current Gene Therapy Recent Advances in the Imaging of Programmed Cell Death
Current Pharmaceutical Design Mouse Models of Multiple Sclerosis: Lost in Translation?
Current Pharmaceutical Design Alkaloids from Piper: A Review of its Phytochemistry and Pharmacology
Mini-Reviews in Medicinal Chemistry PTD/CPP Peptide-Mediated Delivery of siRNAs
Current Pharmaceutical Design Rashes, Sniffles, and Stroke: A Role for Infection in Ischemic Stroke of Childhood
Infectious Disorders - Drug Targets